Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01896687 · ClinicalTrials.gov registry record · NA

Trial of Scrambler Therapy or Sham Treatment for Low Back Pain

A NA study of Low Back Pain, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01896687: Completed NA study of Low Back Pain, sponsored by Virginia Commonwealth University.

NCT01896687 is a NA study of Low Back Pain that has completed, run by Virginia Commonwealth University. The registered enrollment target is 30 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01896687, a NA study of Low Back Pain, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This pilot study will evaluate Scrambler therapy and Sham treatment on levels of low back pain, pain sensitivity and mRNA expression of pain sensitivity candidate genes.

Primary Outcome

Low back pain will be measured by the Brief Pain Inventory (BPI). The BPI assesses the severity of pain, location of pain, pain medications, amount of pain relief in the past 24 hours and the past week, and the impact of pain on daily functions. For this study, the worst pain score will be used in the analysis. The worst pain score is rated from "0" meaning no pain to "10" meaning pain as bad as you can imagine.

Conditions Studied

Interventions

  • DEVICE Scrambler

Study Locations (1)

Virginia

  • Virginia Commonwealth University School of Nursing - Richmond

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-03
Est. Completion 2013-08
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT01896687 record still lists

NCT01896687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Scrambler is the first listed.

NCT01896687 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT01896687 about?

NCT01896687 is a clinical study titled "Trial of Scrambler Therapy or Sham Treatment for Low Back Pain". This pilot study will evaluate Scrambler therapy and Sham treatment on levels of low back pain, pain sensitivity and mRNA expression of pain sensitivity candidate genes.

What is the current status of trial NCT01896687?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-03. Estimated completion is 2013-08.

What conditions does trial NCT01896687 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT01896687?

The interventions under investigation include: Scrambler (DEVICE).

Who is sponsoring clinical trial NCT01896687?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01896687 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01896687's enrollment target sits among peer trials

30 106th of 122 higher than 13 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01896687, the US trial registry maintained by the National Library of Medicine. NCT01896687 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.